July 18, 2024 - $Intuitive Surgical (ISRG.US)$ shares rose 6.81% to $444.49 in post-market trading on Thursday. The company announced financial results for the quarter ended June 30, 2024.
Q2 Highlights
Worldwide da Vinci procedures grew approximately 17% compared with the second quarter of 2023.
The Company placed 341 da Vinci surgical systems, compared with 331 in the second quarter of 2023. The second quarter 2024 da Vinci surgical system placements included 70 da Vinci 5 systems.
The Company grew its da Vinci surgical system installed base to 9,203 systems as of June 30, 2024, an increase of 14% compared with 8,042 as of the end of the second quarter of 2023.
Second quarter 2024 revenue of $2.01 billion increased 14% compared with $1.76 billion in the second quarter of 2023.
Second quarter 2024 GAAP net income attributable to Intuitive was $527 million, or $1.46 per diluted share, compared with $421 million, or $1.18 per diluted share, in the second quarter of 2023.
Second quarter 2024 non-GAAP net income attributable to Intuitive was $641 million, or $1.78 per diluted share, compared with $507 million, or $1.42 per diluted share, in the second quarter of 2023.
About Company
$Intuitive Surgical (ISRG.US)$, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
2024年7月18日 - $直覺外科公司 (ISRG.US)$週四美股盤後，$Intuitive Surgical（ISRG.US）$股價上漲6.81％，至444.49美元。該公司公佈了截至2024年6月30日的季度財務業績。
第二季度亮點
與2023年第二季度相比，全球達芬奇手術數量增長約17%。
公司在2023年第二季度相比於331臺，2024年第二季度放置了341臺達芬奇手術系統。2024年第二季度的da Vinci手術系統放置包括70臺da Vinci 5系統。
截至2024年6月30日，該公司將其達芬奇手術系統安裝量提升至9,203套，相比2023年第二季度末的8,042套增長了14％。
2024年第二季度營業收入爲20.1億美元，比2023年第二季度的17.6億美元增長14%。
2024年第二季度Intuitive歸屬的GAAP淨收入爲52700萬美元，每股攤薄收益1.46美元，相比2023年第二季度的42100萬美元，每股攤薄收益1.18美元有所增長。
2024年第二季度，除特定項目影響之外，直覺外科公司淨利潤爲64100萬美元，每股攤薄收益爲1.78美元，相比2023年第二季度的50700萬美元淨利潤和每股攤薄收益1.42美元有所增長。
關於公司
$直覺外科公司 (ISRG.US)$作爲全球微創醫療領導者和機器人輔助手術的先鋒，該公司的產品包括Da Vinci外科手術系統和Ion內窺鏡系統。這家公司由Frederic H. Moll、John Gordon Freund和Robert G. Younge於1995年11月創立，總部位於加州的Sunnyvale市。
